Docoh
Loading...

Joshua A Kazam

Joshua A Kazam is a director of Allogene Therapeutics Inc.

Person profile

Address
New York, New York
Employees
SEC CIK

Calendar

19 Jan 22
Date Company Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
12 Jan 22 ALLO Allogene Therapeutics Common Stock Buy Acquire P No No 12.6 15,000 189K 258,885
22 Jun 21 KRON Kronos Bio Stock Option Common Stock Grant Acquire A No No 24.18 20,600 498.11K 20,600
11 Jun 21 ALLO Allogene Therapeutics Common Stock Gift Dispose G No No 0 500,000 0 243,885
10 Jun 21 ALLO Allogene Therapeutics Common Stock Grant Acquire A No No 0 16,498 0 743,885
4 Jun 21 LTCH Latch Class A Common Stock Option exercise Acquire M No No 0 30,000 0 30,000
4 Jun 21 LTCH Latch Class B common stock Class A common stock Option exercise Dispose M No No 0 30,000 0 0

Financial reports

No filings

Current reports

No filings

Registration and prospectus

No filings

Proxies

No filings

Other

No filings